Sandra M. Swain

Also affiliated with Georgetown University Medical Center, MedStar Health

Biochemistry, Genetics and Molecular BiologyMedicine

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 100%percentile

0Author DataRank

Indexed papers

0in pilot corpus

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Papers

Driven by 20 papers. Top paper: “Definitive results of a phase III adjuvant trial comparing six cycles of FEC-100 to four cycles of AC in women with operable node-negative breast cancer: the NSABP B-36 trial (NRG Oncology)”.

Definitive results of a phase III adjuvant trial comparing six cycles of FEC-100 to four cycles of AC in women with operable node-negative breast cancer: the NSABP B-36 trial (NRG Oncology)

Breast Cancer Research and Treatment(2022)10.1007/s10549-021-06417-y

N/A

0.593DataRank · unranked

10 citations

Hanna Bandos, Priya Rastogi, Samuel A. Jacobs, André Robidoux, Louis Fehrenbacher +13 more

Long-term follow-up assessment of cardiac safety in SAFE-HEaRt, a clinical trial evaluating the use of HER2-targeted therapies in patients with HER2-positive breast cancer and compromised heart function.

Journal of Clinical Oncology(2020)10.1200/jco.2020.38.15_suppl.12069

N/A

0DataRank · unranked

0 citations

Ana Barac, Filipa Lynce, Xue Geng, Chau T. Dang, Anthony F. Yu +13 more

The tumor immune microenvironment of primary and metastatic HER2− positive breast cancers utilizing gene expression and spatial proteomic profiling

Journal of Translational Medicine(2021)10.1186/s12967-021-03113-9

N/A

0DataRank · unranked

33 citations

S. Church, Tyler Hether, Krysta Chaldekas, Briana M. Hudson, Andrew White +4 more

Multisite evaluation of institutional processes and implementation determinants for pharmacogenetic testing to guide antidepressant therapy

Clinical and Translational Science(2021)10.1111/cts.13154

N/A

0DataRank · unranked

30 citations

Ramzi G. Salloum, Amanda L. Elchynski, D. Max Smith, Elizabeth J. Rowe, Kathryn Blake +24 more

Breast Cancer Index (BCI) and prediction of benefit from extended aromatase inhibitor (AI) therapy (tx) in HR+ breast cancer: NRG oncology/NSABP B-42.

Journal of Clinical Oncology(2021)10.1200/jco.2021.39.15_suppl.501

N/A

0DataRank · unranked

22 citations

Hanna Bandos, Priya Rastogi, Yi Zhang, Kai Treuner, Peter C. Lucas +14 more

Utility of the 70-gene MammaPrint assay for prediction of benefit from extended letrozole therapy (ELT) in the NRG Oncology/NSABP B-42 trial.

Journal of Clinical Oncology(2021)10.1200/jco.2021.39.15_suppl.502

N/A

0DataRank · unranked

16 citations

Hanna Bandos, Peter C. Lucas, L. J. van ‘t Veer, Jia-Perng Jennifer Wei, Charles E. Geyer +15 more

Definitive Results of a Phase III Adjuvant Trial Comparing Six Cycles of FEC-100 to Four Cycles of AC in Women with Operable Node-negative Breast Cancer: The NSABP B-36 Trial (NRG Oncology)

Research Square(2021)10.21203/rs.3.rs-841103/v1

N/A

0DataRank · unranked

3 citations

Hanna Bandos, Priya Rastogi, Samuel A. Jacobs, André Robidoux, Louis Fehrenbacher +13 more

The tumor immune microenvironment of primary and metastatic HER2- positive breast cancers utilizing gene expression and spatial proteomic profiling

Research Square(2021)10.21203/rs.3.rs-625718/v1

N/A

0DataRank · unranked

1 citations

S. Church, Tyler Hether, Krysta Chaldekas, Briana M. Hudson, Andrew White +4 more

Multidisciplinary clinical guidance on trastuzumab deruxtecan (T-DXd)–related interstitial lung disease/pneumonitis—Focus on proactive monitoring, diagnosis, and management

Cancer Treatment Reviews(2022)10.1016/j.ctrv.2022.102378

N/A

0DataRank · unranked

170 citations

Mizuki Nishino, Lisa Lancaster, Bob T. Li, Andrew G. Nicholson, Brian J. Bartholmai +9 more

Ten-year update: NRG Oncology/National Surgical Adjuvant Breast and Bowel Project B-42 randomized trial: extended letrozole therapy in early-stage breast cancer

JNCI Journal of the National Cancer Institute(2023)10.1093/jnci/djad078

N/A

0DataRank · unranked

20 citations

Hanna Bandos, Priya Rastogi, Barry C. Lembersky, Jong‐Hyeon Jeong, Charles E. Geyer +11 more

Optimal adjuvant therapy in older (≥70 years of age) women with low-risk early-stage breast cancer

npj Breast Cancer(2023)10.1038/s41523-023-00591-6

N/A

0DataRank · unranked

12 citations

Julia White, Sandra M. Swain, Eileen Rakovitch, Reshma Jagsi, Timothy J. Whelan +2 more

DPYD Testing: Time to Put Patient Safety First

Journal of Clinical Oncology(2023)10.1200/jco.22.02364

N/A

0DataRank · unranked

40 citations

Susan E. Bates, Gabriel A. Brooks, William L. Dahut, Robert B. Diasio, Wafik S. El‐Deiry +17 more

Data from Gene Expression Profile and Angiogenic Markers Correlate with Response to Neoadjuvant Bevacizumab Followed by Bevacizumab plus Chemotherapy in Breast Cancer

(2023)10.1158/1078-0432.c.6516904

N/A

0DataRank · unranked

0 citations

Seth M. Steinberg, Dat Tien Nguyen, Thomas D. Wu, Zora Modrušan, Sandra M. Swain +1 more

Data from Gene Expression Profile and Angiogenic Markers Correlate with Response to Neoadjuvant Bevacizumab Followed by Bevacizumab plus Chemotherapy in Breast Cancer

(2023)10.1158/1078-0432.c.6516904.v1

N/A

0DataRank · unranked

0 citations

Seth M. Steinberg, Dat Tien Nguyen, Thomas D. Wu, Zora Modrušan, Sandra M. Swain +1 more

iGenSig-Rx: an integral genomic signature based white-box tool for modeling cancer therapeutic responses using multi-omics data

Research Square(2023)10.21203/rs.3.rs-3649238/v1

N/A

0DataRank · unranked

0 citations

Min Sun, Yiheng Hu, Yue Wang, Md. Nazrul Islam, David Goerlitz +6 more

Prognostic value of residual disease (RD) biology and gene expression changes during the neoadjuvant treatment in patients with HER2-positive early breast cancer (EBC)

Annals of Oncology(2024)10.1016/j.annonc.2024.12.010

N/A

0DataRank · unranked

3 citations

Maki Tanioka, Sung Gwe Ahn, Paola Zagami, Tomás Pascual, Mattia Rediti +18 more

Pharmacokinetics and pharmacogenomics of ribociclib in black patients with metastatic breast cancer the LEANORA study

npj Breast Cancer(2024)10.1038/s41523-024-00692-w

N/A

0DataRank · unranked

1 citations

Dylan M. Smith, Cody Peer, Tristan M. Sissung, Keith T. Schmidt, Ming Tan +16 more

iGenSig-Rx: an integral genomic signature based white-box tool for modeling cancer therapeutic responses using multi-omics data

BMC Bioinformatics(2024)10.1186/s12859-024-05835-1

N/A

0DataRank · unranked

0 citations

Min Sun, Yiheng Hu, Yue Wang, Md. Nurul Islam, David Goerlitz +6 more

Risk factors for inflammatory and non-inflammatory breast cancer in North Africa

Breast Cancer Research and Treatment(2020)10.1007/s10549-020-05864-3

N/A

0DataRank · unranked

9 citations

Ahmed Hablas, Ibrahim AbdelBar Seif Eldein, Rabab Gaafar, H. Raïs, Amel Mézlini +17 more

Pharmacokinetics and Pharmacogenomics of Ribociclib in Black Patients with Metastatic Breast Cancer: The LEANORA study

Research Square(2024)10.21203/rs.3.rs-4656461/v1

N/A

0DataRank · unranked

0 citations

Ilana Schlam, Dylan M. Smith, Cody Peer, Tristan M. Sissung, Keith T. Schmidt +16 more